"At $200 a script they have received payment for 62 scripts by 30 Sept."
"So in 2 1/2 months they sold 62 units on the special access scheme?"
How would you know how many they sold but had not received payment for in that quarter? As far as I can see, we only can see payment received, not units sold.
"• Special Access Scheme (SAS): In early August, select patients received SPONTAN via the SAS, allowing forcase-by-case prescriptions. • Authorised Prescriber Scheme (APS): On 16 August, SPONTAN was prescribed to the first patients underthe APS. This scheme allows registered medical practitioners to prescribe SPONTAN to a broader class ofpatients with erectile dysfunction, streamlining access for those who may benefit from this innovativetreatment."
Most sales would be under the APS which began on 16th August. Many more sales were likely made in September than in the half month beginning 16th of August through APS. It's likely or certainly at least possible, that LTR does not receive payment for sales in September until after the end of September. So I don't think the cash receipts to end of September are any real guide on how many sales have been made under these early access schemes. Unit sales could easily be more than double what the cash receipts imply.
LTP Price at posting:
$1.18 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)